SCHEMBL6067586

SCHEMBL6067586

CCCCOc1c2cc(CCl)cc1Cc1cc(CCl)cc(c1OCCCC)Cc1cc(CCl)cc(c1OCCCC)Cc1cc(CCl)cc(c1OCCCC)C2

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TLR4 O00206 7/20 0.42
▸ CD14 P08571 7/20 0.42
▸ LY96 Q9Y6Y9 7/20 0.42
▸ THRA P10827 4/20 0.41
▸ THRB P10828 4/20 0.41
▸ GSTA1 P08263 3/20 0.40
▸ GSTP1 P09211 3/20 0.40
▸ TSHR P16473 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PTPRC P08575 1/20 0.33
▸ PTPN2 P17706 1/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ PTPRB P23467 1/20 0.33
▸ PTPN11 Q06124 1/20 0.33
▸ HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16440318 0.78 THRA (0.42) THRATHRB
SCHEMBL6067644 0.78 TLR4 (0.43) TLR4CD14LY96THRATHRB
SCHEMBL14353074 0.78 TLR4 (0.43) TLR4CD14LY96THRATHRB
SCHEMBL6395446 0.75 MAPT (0.39) HTR2A
SCHEMBL6067581 0.74 GSTA1 (0.43) TLR4CD14LY96THRATHRB
SCHEMBL13309593 0.73 LTA4H (0.42) TSHRNPC1RAB9A
SCHEMBL16440321 0.73 PLA2G2A (0.44) TSHRNPC1RAB9A
SCHEMBL30702676 0.73 GSTA1 (0.57) TLR4CD14LY96GSTA1GSTP1
SCHEMBL6067606 0.73 GSTA1 (0.57) TLR4CD14LY96GSTA1GSTP1
SCHEMBL14353332 0.72 GSTA1 (0.47) TLR4CD14LY96THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006056182-A1 NOVEL ACTIVE SUBSTANCES FOR TREATING, DIAGNOSING AND PREVENTING MACULAR DEGENERATION PHILIPPS-UNIVERSITÄT MARBURG (DE) 2006-06-01 — — WO disclosed
Send feedback